Back to List View Graph View

Compound 2

“Compound 2” is a study-specific designation applied to different chemical entities in the biomedical literature rather than to one uniquely defined molecule.

Where the papers sit

8 papers from the last 6 months study compound 2 directly · updated from PubMed 27 Oct 2026

Study type 0 clinical trials · 8 preclinical

Themes one subject

Those 8 are all about one subject.

  • Bioactive Small-Molecule Discovery

    Natural products and designed small molecules are being explored as sources of new bioactive agents. Cytotoxicity, antiproliferative activity and disease-relevant pathway modulation recur across the studies. The work spans autotaxin, CCN1, A2A adenosine receptors and boron delivery, alongside structural elucidation of diverse metabolites. No single disease, target or mechanism dominates, leaving target validation and therapeutic selectivity as open questions.

    8 papers

Papers

The 8 papers from the last 6 months that study compound 2 directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Bioactive Small-Molecule Discovery (8)
  1. Identification of New Putative Autotaxin Inhibitors via Structure-Based Virtual Screening and Evaluation of Their Antiproliferative Properties Against Ovarian and Breast Cancer Cells. ChemMedChem · 1 Sept 2026 PMID 42675576
  2. Exolide A, structurally diverse Ent-18-norbeyerane diterpenoid from the stems of Indian mangrove plant, Excoecaria agallocha Linn. Fitoterapia · 29 Aug 2026 PMID 42668099
  3. Discovery of Monoterpenoid Indole Alkaloids Targeting CCN1 to Suppress Autophagy for the Treatment of Hypoxic Kidney Injury. Journal of medicinal chemistry · 23 Aug 2026 PMID 42632911
  4. Cytotoxic sesquiterpene alkaloids isolated from Nuphar pumila (Timm) de Candolle. Fitoterapia · 1 Aug 2026 PMID 42542302
  5. Cytotoxic indole diterpenoids from the fungus Aspergillus pseudonomius: isolation, structural elucidation, and biological evaluation. Bioorganic chemistry · 6 Jul 2026 PMID 42407346
  6. Design, synthesis, and pharmacological evaluation of thiazolo[5,4-d]pyrimidines hybridized with lipoic acid or catechol. Novel A2A adenosine receptor antagonists in neuroinflammatory diseases. Bioorganic chemistry · 26 Jun 2026 PMID 42361677
  7. Design, synthesis and biological evaluation of boronic acid-containing quinoxaline derivatives as potential boron carriers for boron neutron capture therapy. Bioorganic chemistry · 17 Jun 2026 PMID 42308785
  8. Cytotoxic spirocyclic polyketides and γ-lactones from endophytic fungus Talaromyces purpureogenus Y21 guided by molecular networking and SMART strategies. Phytochemistry · 21 May 2026 PMID 42167708

By study type

Preclinical: animal, cell and lab studies (8)
  1. Identification of New Putative Autotaxin Inhibitors via Structure-Based Virtual Screening and Evaluation of Their Antiproliferative Properties Against Ovarian and Breast Cancer Cells. ChemMedChem · 1 Sept 2026 PMID 42675576
  2. Exolide A, structurally diverse Ent-18-norbeyerane diterpenoid from the stems of Indian mangrove plant, Excoecaria agallocha Linn. Fitoterapia · 29 Aug 2026 PMID 42668099
  3. Discovery of Monoterpenoid Indole Alkaloids Targeting CCN1 to Suppress Autophagy for the Treatment of Hypoxic Kidney Injury. Journal of medicinal chemistry · 23 Aug 2026 PMID 42632911
  4. Cytotoxic sesquiterpene alkaloids isolated from Nuphar pumila (Timm) de Candolle. Fitoterapia · 1 Aug 2026 PMID 42542302
  5. Cytotoxic indole diterpenoids from the fungus Aspergillus pseudonomius: isolation, structural elucidation, and biological evaluation. Bioorganic chemistry · 6 Jul 2026 PMID 42407346
  6. Design, synthesis, and pharmacological evaluation of thiazolo[5,4-d]pyrimidines hybridized with lipoic acid or catechol. Novel A2A adenosine receptor antagonists in neuroinflammatory diseases. Bioorganic chemistry · 26 Jun 2026 PMID 42361677
  7. Design, synthesis and biological evaluation of boronic acid-containing quinoxaline derivatives as potential boron carriers for boron neutron capture therapy. Bioorganic chemistry · 17 Jun 2026 PMID 42308785
  8. Cytotoxic spirocyclic polyketides and γ-lactones from endophytic fungus Talaromyces purpureogenus Y21 guided by molecular networking and SMART strategies. Phytochemistry · 21 May 2026 PMID 42167708